Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phase 2 Partners, LLC is an active hedge fund and investment adviser focused on the financials sector. The firm manages discretionary assets totaling approximately $487 million as of March 2024 and reported $133 million in managed securities in its latest filings. Its portfolio includes investments in public equities such as Encore Capital Group, Mercury General Corporation, Kemper Corporation, Willis Lease Finance Corporation, and HCI Group. The fund employs a fundamentals-driven long-short strategy targeting mispriced equities within financials, fintech, insurance, and housing sectors
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 2nd Phase Partners.